With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
The Graded Prognostic Assessment (GPA) is a tool to help predict survival of patients with brain mets and it’s now here for small cell lung cancer as well as for non-small cell lung cancer with PD-L1 expression, available as an online tool of course. | Sperduto, Int J Radiat Oncol Biol Phys 2022